MOH — authorised 23 March 2022
- Marketing authorisation holder: AAA USA NOVARTIS
- Status: likely_approved
MOH authorised Pluvicto on 23 March 2022
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 23 March 2022.
AAA USA NOVARTIS holds the UAE marketing authorisation.